Decentralized Trials Expand Access—but Risk Inequity
Conexiant
April 15, 2026
The RESOLVE trial showed underrepresentation of Hispanic participants, highlighting inequities in decentralized trials.
Decentralized trials may shift participation barriers rather than eliminate them, affecting trial inclusivity.
Remote trials rely on technology that may disadvantage populations with lower digital fluency or access.
Hybrid trial models can enhance diversity by combining in-person and remote participation options.
Trial design must prioritize representativeness to ensure findings are generalizable across diverse populations.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: